View Item 

Show simple item record

Acute megakaryocytic leukemia presenting as hypercalcemia with skeletal lytic lesions

dc.contributor.authorMuler, Jeffrey H.en_US
dc.contributor.authorValdez, Riccardoen_US
dc.contributor.authorHayes, Curtis W.en_US
dc.contributor.authorKaminski, Mark S.en_US
dc.date.accessioned2010-06-01T22:19:14Z
dc.date.available2010-06-01T22:19:14Z
dc.date.issued2002-06en_US
dc.identifier.citationMuler, Jeffrey H.; Valdez, Riccardo; Hayes, Curtis; Kaminski, Mark S. (2002). "Acute megakaryocytic leukemia presenting as hypercalcemia with skeletal lytic lesions." European Journal of Haematology 68(6): 392-396. <http://hdl.handle.net/2027.42/75331>en_US
dc.identifier.issn0902-4441en_US
dc.identifier.issn1600-0609en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/75331
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12225399&dopt=citationen_US
dc.description.abstractAcute megakaryocytic leukemia (AML M7) is a rare type of acute myelogenous leukemia in adults, commonly presenting with myelofibrosis. This report describes a case of a 32-yr-old male who presented with hypercalcemia and bony lytic lesions, in the absence of myelofibrosis. The diagnosis of AML M7 should be considered in a patient with pancytopenia, lytic lesions and hypercalcemia.en_US
dc.format.extent415940 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherMunksgaard International Publishersen_US
dc.publisherBlackwell Publishing Ltden_US
dc.rights© Blackwell Munksgaard 2002en_US
dc.subject.otherAcute Megakaryocytic Leukemiaen_US
dc.subject.otherHypercalcemiaen_US
dc.subject.otherLytic Lesionsen_US
dc.titleAcute megakaryocytic leukemia presenting as hypercalcemia with skeletal lytic lesionsen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of Hematology/Oncology, University of Michigan Cancer Center, Ann Arbor, Michigan, USAen_US
dc.identifier.pmid12225399en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/75331/1/j.1600-0609.2002.02715.x.pdf
dc.identifier.doi10.1034/j.1600-0609.2002.02715.xen_US
dc.identifier.sourceEuropean Journal of Haematologyen_US
dc.identifier.citedreferenceMoody A, Simpson E, Shaw D. Florid radiological appearance of megakaryoblastic leukemia – an aid to diagnosis. Pediatr Radiol 1989; 19: 486 – 488.en_US
dc.identifier.citedreferenceFisher D, Ruchlemer R, Hiller N, et al. Aggressive bone destruction in acute megakaryocytic leukemia: a rare presentation. Pediatr Radiol 1997; 27: 20 – 22.en_US
dc.identifier.citedreferenceKozlowski K, Halimun E. Generalized bone disease with abundant periosteal reaction in megakaryocytic leukemia. Eur J Pediatr 1997; 156: 845 – 847.en_US
dc.identifier.citedreferenceAbrahamsson J, Swolin B, Mellander L. Bone marrow fibrosis and radiological changes of the long bones in children with acute megakaryocytic leukaemia. Acta Paediatr 1998; 87: 1093 – 1096.en_US
dc.identifier.citedreferenceDharmasena F, Wickham N, McHugh P, et al. Osteolytic tumors in acute megakaryoblastic leukemia. Cancer 1986; 58: 2273.en_US
dc.identifier.citedreferenceGewirtz AM, Stewart AF, Vignery A, et al. Hypercalcemia complicating acute myelogenous leukemia: a syndrome of multiple etiologies. Br J Haematol 1983; 54: 133 – 141.en_US
dc.identifier.citedreferenceTallman MS, Neuberg D, Bennett JM, et al. Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience. Blood 2000; 96: 2405 – 2411.en_US
dc.identifier.citedreferenceSimon JH, Tebbi CK, Freeman AI, et al. Acute megakaryoblastic leukemia associated with mosaic Down's syndrome. Cancer 1987; 60: 2515 – 2520.en_US
dc.identifier.citedreferenceRuiz-Arguelles GJ, Lobato-Mandiazabal E, San Miguel JF, et al. Long term treatment results for acute megakaryoblastic leukemia patients. A multicenter study. Br J Haematol 1992; 82: 671 – 675.en_US
dc.identifier.citedreferenceKosmidis PA, Palacas CG, Axelrod AR. Diffuse purely osteolytic lesions in myelofibrosis. Cancer 1980; 46: 2263 – 2265.en_US
dc.identifier.citedreferenceWong KF, Chan JK, Ma SK, Chu YC. Megakaryoblastic transformation of polycythemia vera associated with hypercalcemia. Am J Hematol 1993; 43: 240.en_US
dc.identifier.citedreferenceKumar S, Mow B, Kaufmann S. Hypercalcemia complicating leukemic transformation of agnogenic myeloid metaplasia – myelofibrosis. Mayo Clin Proc 1999; 74: 1233 – 1237.en_US
dc.identifier.citedreferenceKornberg A, Amir G, Leizerowitz R, Rachmilewitz EA. Hypercalcemia complicating a megakaryoblastic crisis of chronic myelogenous leukemia. Isr J Med Sci 1988; 24: 247 – 249.en_US
dc.identifier.citedreferenceZidar B, Shadduck R, Winkelstein A, Zeigler Z, Hawker C. Acute myeloblastic leukemia and hypercalcemia. N Engl J Med 1976; 295: 692 – 694.en_US
dc.identifier.citedreferenceBolodeoku J, Kusec R. Parathyroid hormone related protein (PTHrP) in acute myeloid leukaemia cells. Br J Haematol 1997; 98: 245 – 246.en_US
dc.identifier.citedreferenceVoss A, Schmidt K, Hasselbalch, Junker P. Hypercalcemia in idiopathic fibrosis. Modulation of calcium and collagen homeostasis by 1,25-dihydroxyvitamin D3. Am J Hematol 1992; 39: 231 – 233.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1600-0609.2002.02715.x.pdf
Size:
406.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.